Antigenic characterization of an intrinsically unstructured protein, Plasmodium falciparum merozoite surface protein 2

Infection and Immunity

Volumn 80, Issue 12, 2012, Pages 4177-4185

  Adda, Christopher G ^a   MacRaild, Christopher A ^b   Reiling, Linda ^c   Wycherley, Kaye ^d   Boyle, Michelle J ^c   Kienzle, Vivian ^a,e   Masendycz, Paul ^d   Foley, Michael ^a   Beeson, James G ^c   Norton, Raymond S ^b   Anders, Robin F ^a  

^a LA TROBE UNIVERSITY   (Australia)

^b MONASH UNIVERSITY   (Australia)

^c BURNET INSTITUTE   (Australia)

^d WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

^e QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; MEROZOITE SURFACE PROTEIN 2; MONOCLONAL ANTIBODY; PARASITE ANTIGEN; RECOMBINANT PROTEIN;

AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; EPITOPE MAPPING; FEMALE; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN CONFORMATION; PROTEIN STRUCTURE;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, PROTOZOAN; EPITOPE MAPPING; FEMALE; MAGNETIC RESONANCE SPECTROSCOPY; MICE; MICE, INBRED CBA; PLASMODIUM FALCIPARUM; PROTEIN CONFORMATION; PROTOZOAN PROTEINS; RECOMBINANT PROTEINS;

EID: 84870826346     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.00665-12     Document Type: Article

References (57)

1. Adda CG, et al. 2009. Plasmodium falciparum merozoite surface protein 2 is unstructured and forms amyloid-like fibrils. Mol. Biochem. Parasitol. 166:159-171.
2. Anders RF, et al. 1998. Immunisation with recombinant AMA-1 protects mice against infection with Plasmodium chabaudi. Vaccine 16:240-247.
3. Angov E, et al. 2003. Development and pre-clinical analysis of a Plasmo-dium falciparum merozoite surface protein-1(42) malaria vaccine. Mol. Biochem. Parasitol. 128:195-204.
4. Barry AE, Schultz L, Buckee CO, Reeder JC. 2009. Contrasting population structures of the genes encoding ten leading vaccine-candidate antigens of the human malaria parasite, Plasmodium falciparum. PLoS One 4:e8497. doi:10.1371/journal.pone.0008497.
5. Blackman MJ, Ling IT, Nicholls SC, Holder AA. 1991. Proteolytic processing of the Plasmodium falciparum merozoite surface protein-1 produces amembrane-bound fragment containing two epidermal growth factor-like domains. Mol. Biochem. Parasitol. 49:29-33.
6. Blackman MJ, Scott-Finnigan TJ, Shai S, Holder AA. 1994. Antibodies inhibit the protease-mediated processing of a malaria merozoite surface protein. J. Exp. Med. 180:389-393.
7. Bouharoun-Tayoun H, Attanath P, Sabchareon A, Chongsuphajaisid-dhi T, Druilhe P. 1990. Antibodies that protect humans against Plasmo-dium falciparum blood stages do not on their own inhibit parasite growth and invasion in vitro, but act in cooperation with monocytes. J. Exp. Med. 172:1633-1641.
8. Cao J, et al. 2009. Rhoptry neck protein RON2 forms a complex with microneme protein AMA1 in Plasmodium falciparum merozoites. Parasi-tol. Int. 58:29-35.
9. Chang SP, Gibson HL, Lee-Ng CT, Barr PJ, Hui GS. 1992. A carboxyl-terminal fragment ofPlasmodium falciparum gp195 expressed byarecom-binant baculovirus induces antibodies that completely inhibit parasite growth. J. Immunol. 149:548-555.
10. Clark JT, et al. 1989. 46-53 kilodalton glycoprotein from the surface of Plasmodium falciparum merozoites. Mol. Biochem. Parasitol. 32:15-24.
11. Coley AM, et al. 2001. Rapid and precise epitope mapping of monoclonal antibodies against Plasmodium falciparum AMA1 by combined phage display of fragments and random peptides. Protein Eng. 14:691-698.
12. Conway DJ, Polley SD. 2002. Measuring immune selection. Parasitology 125(Suppl):S3-S16.
13. Dutta S, Haynes JD, Moch JK, Barbosa A, Lanar DE. 2003. Invasion-inhibitory antibodies inhibit proteolytic processing of apical membrane antigen 1 of Plasmodium falciparum merozoites. Proc. Natl. Acad. Sci. U. S. A. 100:12295-12300.
14. Ekala MT, Jouin H, Lekoulou F, Mercereau-Puijalon O, Ntoumi F. 2002. Allelic family-specific humoral responses to merozoite surface protein 2 (MSP2) in Gabonese residents with Plasmodium falciparum infections. Clin. Exp. Immunol. 129:326-331.
15. Epping RJ, et al. 1988. An epitope recognised by inhibitory monoclonal antibodies that react with a 51 kilodalton merozoite surface antigen in Plasmodium falciparum. Mol. Biochem. Parasitol. 28:1-10.
16. Feng ZP, et al. 2006. Abundance of intrinsically unstructured proteins in P. falciparum and other apicomplexan parasite proteomes. Mol. Biochem. Parasitol. 150:256-267.
17. Fenton B, et al. 1991. Structural and antigenic polymorphism of the 35-to 48-kilodalton merozoite surface antigen (MSA-2) of the malaria parasite Plasmodium falciparum. Mol. Cell. Biol. 11:963-971.
18. Fluck C, et al. 2004. Strain-specific humoral response to a polymorphic malaria vaccine. Infect. Immun. 72:6300-6305.
19. Flueck C, et al. 2009. Evaluation of two long synthetic merozoite surface protein 2 peptides as malaria vaccine candidates. Vaccine 27:2653-2661.
20. Genton B, et al. 2002. A recombinant blood-stage malaria vaccine reduces Plasmodium falciparum density and exerts selective pressure on parasite populations in a phase 1-2b trial in Papua New Guinea. J. Infect. Dis. 185:820-827.
21. Guevara Patino JA, Holder AA, McBride JS, Blackman MJ. 1997. Antibodies that inhibit malaria merozoite surface protein-1 processing and erythrocyte invasion are blocked by naturally acquired human antibodies. J. Exp. Med. 186:1689-1699.
22. Hodder AN, Crewther PE, Anders RF. 2001. Specificity of the protective antibody response to apical membrane antigen 1. Infect. Immun. 69: 3286-3294.
23. Hodder AN, et al. 1996. The disulfide bond structure of Plasmodium apical membrane antigen-1. J. Biol. Chem. 271:29446-29452.
24. Hoffmann EH, et al. 2001. Geographical patterns of allelic diversity in the Plasmodium falciparum malaria-vaccine candidate, merozoite surface protein-2. Ann. Trop. Med. Parasitol. 95:117-132.
25. Holder AA. 2009. The carboxy-terminus of merozoite surface protein 1: structure, specific antibodies and immunity to malaria. Parasitology 136: 1445-1456.
26. Kadekoppala M, Holder AA. 2010. Merozoite surface proteins of the malaria parasite: the MSP1 complex and the MSP7 family. Int. J. Parasitol. 40:1155-1161.
27. Kennedy MC, et al. 2002. In vitro studies with recombinant Plasmodium falciparum apical membrane antigen 1 (AMA1): production and activity of an AMA1 vaccine and generation of a multiallelic response. Infect. Immun. 70:6948-6960.
28. Lamarque M, et al. 2011. The RON2-AMA1 interaction is a critical step in moving junction-dependent invasion by apicomplexan parasites. PLoS Pathog. 7:e1001276. doi:10.1371/journal.ppat.1001276.
29. Ling IT, Ogun SA, Holder AA. 1994. Immunization against malaria with a recombinant protein. Parasite Immunol. 16:63-67.
30. Low A, et al. 2007. Merozoite surface protein 2 of Plasmodium falciparum: expression, structure, dynamics, and fibril formation of the conserved N-terminal domain. Biopolymers 87:12-22.
31. MacRaild CA, Pedersen Mø, Anders RF, Norton RS. 2012. Lipid interactions of the malaria antigen merozoite surface protein 2. Biochim. Bio-phys. Acta 1818:2572-2578.
32. McCarthy JS, et al. 2011. A phase 1 trial of MSP2-C1, a blood-stage malaria vaccine containing 2 isoforms of MSP2 formulated with Mon-tanide ISA 720. PLoS One 6:e24413. doi:10.1371/journal.pone.0024413.
33. Olugbile S, et al. 2009. Vaccine potentials of an intrinsically unstructured fragment derived from the blood stage-associated Plasmodium falciparum protein PFF0165c. Infect. Immun. 77:5701-5709.
34. Osier FH, et al. 2010. Allele-specific antibodies to Plasmodium falciparum merozoite surface protein-2 and protection against clinical malaria. Parasite Immunol. 32:193-201.
35. Ramasamy R. 1987. Studies on glycoproteins in the human malaria parasite Plasmodium falciparum. Identification ofamyristilated 45kDa mero-zoite membrane glycoprotein. Immunol. Cell Biol. 65:419-424.
36. Reddy SB, et al. 2012. High affinity antibodies to Plasmodium falciparum merozoite antigens are associated with protection from malaria. PLoS One 7:e32242. doi:10.1371/journal.pone.0032242.
37. Richard D, et al. 2010. Interaction between Plasmodium falciparum apical membrane antigen 1 and the rhoptry neck protein complex defines a key step inthe erythrocyte invasion process ofmalaria parasites. J.Biol. Chem. 285:14815-14822.
38. Rosen O, Anglister J. 2009. Epitope mapping of antibody-antigen complexes by nuclear magnetic resonance spectroscopy. Methods Mol. Biol. 524:37-57.
39. Sasakawa H, et al. 2007. Ultra-high field NMR studies of antibody binding and site-specific phosphorylation of alpha-synuclein. Biochem. Bio-phys. Res. Commun. 363:795-799.
40. Saul A, et al. 1989. Cross-reactivity of antibody against an epitope of the Plasmodium falciparum second merozoite surface antigen. Parasite Immunol. 11:593-601.
41. Schanda P, Brutscher B. 2005. Very fast two-dimensional NMR spectros-copy for real-time investigation of dynamic events in proteins on the time scale of seconds. J. Am. Chem. Soc. 127:8014-8015.
42. Scopel KK, da Silva-Nunes M, Malafronte RS, Braga EM, Ferreira MU. 2007. Variant-specific antibodies to merozoite surface protein 2 and clinical expression of Plasmodium falciparum malaria in rural Amazonians. Am. J. Trop. Med. Hyg. 76:1084-1091.
43. Sharom FJ, Lehto MT. 2002. Glycosylphosphatidylinositol-anchored proteins: structure, function, and cleavage by phosphatidylinositol-specific phospholipase C. Biochem. Cell Biol. 80:535-549.
44. Shi YP, Udhayakumar V, Oloo AJ, Nahlen BL, Lal AA. 1999. Differential effect and interaction of monocytes, hyperimmune sera, and immuno-globulin G on the growth of asexual stage Plasmodium falciparum parasites. Am. J. Trop. Med. Hyg. 60:135-141.
45. Singh S, et al. 2006. Immunity to recombinant Plasmodium falciparum merozoite surface protein 1 (MSP1): protection in Aotus nancymai monkeys strongly correlates with anti-MSP1 antibody titer and in vitro parasite-inhibitory activity. Infect. Immun. 74:4573-4580.
46. Smythe JA, et al. 1990. Structural diversity in the 45-kilodalton merozoite surface antigen of Plasmodium falciparum. Mol. Biochem. Parasitol. 39: 227-234.
47. Stubbs J, et al. 2011. Strain-transcending Fc-dependent killing of Plas-modium falciparum by merozoite surface protein 2 allele-specific human antibodies. Infect. Immun. 79:1143-1152.
48. Taylor RR, Smith DB, Robinson VJ, McBride JS, Riley EM. 1995. Human antibody response to Plasmodium falciparum merozoite surface protein 2is serogroup specific and predominantly ofthe immunoglobulin G3 subclass. Infect. Immun. 63:4382-4388.
49. Tebo AE, Kremsner PG, Luty AJ. 2001. Plasmodium falciparum: a major role for IgG3 in antibody-dependent monocyte-mediated cellular inhibition of parasite growth in vitro. Exp. Parasitol. 98:20-28.
50. Theisen M, et al. 1998. The glutamate-rich protein (GLURP) of Plasmo-dium falciparum is a target for antibody-dependent monocyte-mediated inhibition of parasite growth in vitro. Infect. Immun. 66:11-17.
51. Thomas AW, Carr DA, Carter JM, Lyon JA. 1990. Sequence comparison of allelic forms of the Plasmodium falciparum merozoite surface antigen MSA2. Mol. Biochem. Parasitol. 43:211-220.
52. Tonkin ML, et al. 2011. Host cell invasion by apicomplexan parasites: insights from the co-structure of AMA1 with a RON2 peptide. Science 333:463-467.
53. Vranken WF, et al. 2005. The CCPN data model for NMR spectroscopy: development of a software pipeline. Proteins 59:687-696.
54. Weedall GD, Conway DJ. 2010. Detecting signatures of balancing selection to identify targets of anti-parasite immunity. Trends Parasitol. 26: 363-369.
55. Weisman S, et al. 2001. Antibody responses to infections with strains of Plasmodium falciparum expressing diverse forms of merozoite surface protein 2. Infect. Immun. 69:959-967.
56. Yang X, et al. 2007. A partially structured region of a largely unstructured protein, Plasmodium falciparum merozoite surface protein 2 (MSP2), forms amyloid-like fibrils. J. Pept. Sci. 13:839-848.
57. Zhang X, et al. 2008. Solution conformation, backbone dynamics and lipid interactions of the intrinsically unstructured malaria surface protein MSP2. J. Mol. Biol. 379:105-121.